Rapid Therapeutic Science Laboratories, Inc. (RTSL)
USD 0.0
(2.56%)
USD 0.0
(2.56%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2022 | 430.23 Thousand USD | -18.63% |
| 2021 | 528.74 Thousand USD | 0.0% |
| 2019 | 2.2 Million USD | 0.0% |
| 2017 | 2.2 Million USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 Q1 | 409.18 Thousand USD | -4.89% |
| 2023 Q2 | 387.89 Thousand USD | -5.2% |
| 2022 Q4 | 430.23 Thousand USD | -8.08% |
| 2022 FY | 430.23 Thousand USD | -18.63% |
| 2022 Q2 | 488.54 Thousand USD | -3.98% |
| 2022 Q1 | 508.76 Thousand USD | -3.78% |
| 2022 Q3 | 468.06 Thousand USD | -4.19% |
| 2021 Q4 | 528.74 Thousand USD | 252.5% |
| 2021 Q3 | 150 Thousand USD | 0.0% |
| 2021 Q2 | 150 Thousand USD | 0.0% |
| 2021 Q1 | 150 Thousand USD | 0.0% |
| 2021 FY | 528.74 Thousand USD | 0.0% |
| 2020 Q1 | 315.24 Thousand USD | -32.24% |
| 2020 Q3 | 315.24 Thousand USD | 0.0% |
| 2020 Q2 | 315.24 Thousand USD | 0.0% |
| 2019 FY | 2.2 Million USD | 0.0% |
| 2019 Q2 | 2.2 Million USD | 0.0% |
| 2019 Q1 | 2.2 Million USD | 0.0% |
| 2019 Q4 | 465.24 Thousand USD | -78.85% |
| 2019 Q3 | 2.2 Million USD | 0.0% |
| 2018 Q3 | 2.2 Million USD | 0.0% |
| 2018 Q1 | 2.2 Million USD | 0.0% |
| 2018 Q2 | 2.2 Million USD | 0.0% |
| 2018 Q4 | 2.2 Million USD | 0.0% |
| 2017 FY | 2.2 Million USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 12.52 Million USD | 96.566% |
| IR-Med Inc. | 161 Thousand USD | -167.227% |
| Polarean Imaging plc | 74.84 Thousand USD | -474.827% |
| Medical Supply International USA, Inc. | 116.05 Thousand USD | -270.72% |
| Avitar, Inc. | 3.89 Million USD | 88.958% |
| AVITA Medical, Inc. | 449.48 Thousand USD | 4.282% |
| Manhattan Scientifics, Inc. | - USD | -Infinity% |
| Össur hf. | 311.8 Million USD | 99.862% |
| Zecotek Photonics Inc. | - USD | -Infinity% |
| QHSLab, Inc. | - USD | -Infinity% |
| Wellstar International, Inc. | 18.86 Million USD | 97.719% |
| Össur hf. | 311.8 Million USD | 99.862% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 618 Thousand USD | 30.383% |
| Escalon Medical Corp. | 279.4 Thousand USD | -53.983% |
| Aurora Spine Corporation | 1.59 Million USD | 72.972% |
| BrainsWay Ltd. | 239 Thousand USD | -80.015% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | - USD | -Infinity% |
| Hamilton Thorne Ltd. | 16.7 Million USD | 97.425% |
| Vivos Inc. | - USD | -Infinity% |
| MicroPort Scientific Corporation | 814.21 Million USD | 99.947% |
| Kelyniam Global, Inc. | 217.61 Thousand USD | -97.708% |
| REMSleep Holdings, Inc. | 43.67 Thousand USD | -885.06% |
| CYduct Diagnostics, Inc. | 590 Thousand USD | 27.079% |
| Nanomix Corporation | 10.11 Million USD | 95.745% |
| Theraclion SA | 1.95 Million EUR | 77.945% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 304.6 Thousand USD | -41.246% |
| Positron Corporation | - USD | -Infinity% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 150 Thousand USD | -186.823% |
| Lombard Medical, Inc. | 28.02 Million USD | 98.465% |
| ALR Technologies Inc. | - USD | -Infinity% |
| Stratec SE | 89.25 Million USD | 99.518% |
| Vycor Medical, Inc. | 243.28 Thousand USD | -76.843% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | - USD | -Infinity% |
| Perimeter Medical Imaging AI, Inc. | 142.32 Thousand USD | -202.282% |
| SANUWAVE Health, Inc. | 492 Thousand USD | 12.554% |
| VMS Rehab Systems, Inc. | 106.45 USD | -404066.275% |
| Guided Therapeutics, Inc. | 511 Thousand USD | 15.805% |
| Ingen Technologies, Inc. | 532.27 Thousand USD | 19.171% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | 804 Thousand USD | 46.488% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 322.4 Thousand USD | -33.447% |
| Urologix, Inc. | 4.58 Million USD | 90.619% |
| Nexeon MedSystems Inc. | 2.78 Million USD | 84.559% |
| SS Innovations International, Inc. | 1.91 Million USD | 77.48% |
| Qualis Innovations, Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 2.17 Billion USD | 99.98% |
| NIOX Group Plc | 500 Thousand USD | 13.953% |
| Fuse Medical, Inc. | 200 Thousand USD | -115.118% |
| Broncus Holding Corporation | 1.22 Million USD | 64.85% |
| Brain Scientific Inc. | 7378.00 USD | -5731.323% |
| Pressure BioSciences, Inc. | 161.86 Thousand USD | -165.8% |
| Health Logic Interactive Inc. | - USD | -Infinity% |